Sandra Aung
Chief Tech/Sci/R&D Officer bei AMBRX INC
Profil
Sandra Aung is currently the Chief Clinical Development Officer & Senior VP at OncoSec Medical, Inc. and the Chief Clinical Officer at Ambrx, Inc. She holds a doctorate degree from Vanderbilt University.
Aktive Positionen von Sandra Aung
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Corporate Officer/Principal | 12.10.2020 |
| AMBRX INC | Chief Tech/Sci/R&D Officer | 01.02.2023 |
Ausbildung von Sandra Aung
| Vanderbilt University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Private Unternehmen | 1 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
